TAMPA — Six weeks in Antarctic waters. Dives to 130 feet. Half-hour bottom times.
And one compound that killed melanoma in mice without killing the mice. Those are the numbers behind a University of South Florida discovery that could, years from now, lead to a drug for the deadliest form of skin cancer.
The raw material came from ascidians — sea squirts — that produce toxins to ward off predators in the icy Southern Ocean. Bill Baker, a USF chemistry professor, put it bluntly: “The good news is it didn’t kill the mice. It did kill their cancer, so we know it has the physiological properties to act like a drug.” The expedition that collected the specimens was funded by the National Science Foundation.
A USF team spent six weeks in one of the most remote places on Earth. Divers descended as deep as 130 feet, staying down for about 30 minutes at a time to gather the ascidians.
Ben Meister, a USF professor who served as the diving safety officer, called the conditions brutal. Baker’s team found that the toxins ascidians produce as chemical defenses can be repurposed to attack cancer cells. The key figure for investors and patients: the compound worked in mice without apparent toxicity to the animals themselves.
That is a critical hurdle in early-stage cancer research. Many compounds that kill cancer cells in a petri dish prove too toxic in live animals. This one did not.
The path from that result to a human drug is long. Baker laid out the steps plainly.
“We need grams of material to do a bigger study in mice, perhaps go into other animal models, and if we can prove the safety, we can actually start some human trials,” he said. That means producing enough purified compound for larger mouse studies. Then testing in other animal models.
Then, if safety holds, applying for permission to test in humans. Each stage is strictly regulated.
Each expands in scale. Each takes time and money. The expedition itself was a serious logistical undertaking.
Antarctica is not a casual collecting site. The divers worked in near-freezing water, under ice, in conditions Meister described as brutal. They brought back ascidians — invertebrates that attach to rocks and filter feed.
Those creatures evolved their chemical arsenal over millions of years in a predator-rich environment. Baker’s insight was that those same chemicals, designed to kill or deter predators, might be turned against cancer cells.
The compound in question targets melanoma, the deadliest form of skin cancer. Melanoma kills thousands of Americans each year. Current treatments include surgery, immunotherapy, and targeted drugs, but advanced cases remain difficult to cure.
A new option, if it clears the long pipeline of trials, would matter. But that pipeline is unforgiving.
Most compounds that show promise in mice never make it to human trials. Of those that do, most fail. The process from discovery to an approved drug typically takes a decade or more and costs hundreds of millions of dollars.
Baker acknowledged the odds. He did not promise a cure. He did not announce a timeline.
He stated what the data show: the compound killed melanoma in mice without killing the mice. That is a first step, not a finish line.
The National Science Foundation funded the collecting expedition. That is public money, spent on basic research with no guarantee of a payoff. The payoff, if it comes, will be years away.
For now, the numbers are what they are: six weeks, 130 feet, 30 minutes, one compound, one set of mice, one result. The mice lived.
Their tumors did not. That is enough to keep the research going.
{“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “USF researchers find Antarctic sea squirt compound kills melanoma in mice”, “description”: “TAMPA — Six weeks in Antarctic waters. Dives to 130 feet. Half-hour bottom times. And one compound that killed melanoma in mice without killing the…”, “datePublished”: “2026-06-29T14:38:00+00:00T09:30:00+00:00”, “author”: {“@type”: “Person”, “name”: “Isabella Moore”}, “publisher”: {“@type”: “Organization”, “name”: “InfoPulse Today”, “url”: “https://newsfeed.2bme.xyz/”}}
